Skip to main content
drug protocol number
1
drug sponsor
King Faisal Specialist Hospital & Research Centre Riyadh, Saudi Arabia
drug study
BRENTUXIMAB VEDOTIN, DACARBAZINE, VINBLASTINE, DOXORUBICIN HYDROCHLORIDE
drug trial site
King Faisal Specialist Hospital and Research Center (Riyadh)
drug status
Rejected
drug phase